# PHASE-2A — MO-029 Review Risk Routing Increment Certification

**Status:** CERTIFIED  
**Date:** 2026-08-15

## Scope

This certification covers the first operational increment of MO-029 risk-tiered review routing.

The increment introduces a generic, product-neutral routing layer over existing reviewer-ready evidence groups. It does not change evidence acceptance, fact creation, applicability, entitlement, currentness, or publication contracts.

## Certified behavior

The routing contract classifies review workload into transparent risk tiers:

```text
critical -> dual_or_senior_review
high     -> senior_review
medium   -> standard_review
low      -> light_review
```

Unknown review signals fail closed rather than receiving an inferred lower-risk route.

The routing output is workload metadata only. It cannot:

- accept or reject evidence;
- create a canonical fact;
- determine legal or product applicability;
- change source/document currentness;
- publish knowledge;
- bypass `ReviewerDecisionRecordContract`.

## Validation

User-run validation on 2026-08-15:

```text
review-risk routing focused   7 passed
governance/health combined   19 passed
tests/health                109 passed
regressions                   0
```

## Architectural conclusion

The existing review pipeline remains safe but structurally linear because each review group still requires an explicit human decision before governed fact selection.

The first MO-029 increment therefore correctly addresses **routing and workload concentration**, not automated adjudication.

This preserves the key distinction:

```text
risk routing != evidence acceptance
risk routing != fact creation
risk routing != publication
```

## Phase-2A implication

MO-029 is now operational enough to be exercised on a multi-insurer onboarding batch and measured for:

- review-group count;
- risk-tier distribution;
- high/critical-review concentration;
- residue;
- fail-closed events;
- product-specific production-code changes.

The standing Phase-2A rule remains:

```text
normal new Health product onboarding
=
0 product-identity-bearing production code
```

## Certification decision

**CERTIFIED — first MO-029 review-risk routing increment.**

This certification does not claim that human review effort is already sub-linear. That must be demonstrated through the upcoming Phase-2A batch measurements.
